Vivgard Hytrulo Pre-Filled Syringe, which contains F-Gartigamide Alpha and Hyaluronidase QVFC
Argenics: Vivgard Hytrulo Pre-Filled Syringe, which contains F-Gartigamide Alpha and… · Jul 10–29, 2026
NewThe campaign promoted the Vivgard Hytrulo Pre-Filled Syringe, which contains F-Gartigamide Alpha and Hyaluronidase QVFC, by emphasizing the convenience and personal control of self-injecting treatment on one's own terms.
13-week activity
Public campaign reads by observed week
Renewal signals
No recurring promo code was observed.
convenience and personal control
Shows
Where the campaign appearedPlacements
Categories
Representative reads
Examples across the campaignExample transcript
The read that best represents this campaign's recurring script
I like things my way, my coffee, my schedule, and my treatment. So I talked to my doctor about self-injecting with the Vivgard Hytrulo Pre-Filled Syringe, which contains F-Gartigamide Alpha and Hyaluronidase QVFC. It's injected under your skin subcutaneously. It means I can inject in my space on my time. It's my treatment, my way. Visit VivGuardMyWay.com. That's V-Y-V-G-A-R-T MyWay.com. And talk to your doctor about VivGuard Hattrulo. Brought to you by Argenics.
More campaigns from Argenics
Other published campaigns from this sponsor
The campaign promotes the Vivgard Hytrulo, Efgard Tigamod Alpha, and Hyaluronidase QVFC pre-filled syringe, emphasizing the convenience and control of self-injection for a flexible treatment routine.
Argenics partners with Ruby Studio to produce "Untold Stories, Life with a Severe Autoimmune Condition," a podcast that explores the experiences of individuals living with various rare autoimmune conditions and fosters a sense of community.
These signals describe observed podcast advertising activity. Per-read dollar figures are directional current placement proxies—not historical campaign spend, reach, conversions, or return on investment.